Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

BRTX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: June 13, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for BioRestorative Therapies Inc (BRTX)

Based on 8 analysts giving stock ratings to BioRestorative Therapies Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
25
Buy
62
Hold
13
Sell
0
Strong Sell
0
BioRestorative Therapies Inc

BioRestorative Therapies Inc. Stock Analysis BRTX

United States Health Care Nano Cap Report:
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. The company is headquartered in Melville, New York and currently employs 13 full-time employees. The company went IPO on 2001-07-11. The firm has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. The company has commenced a Phase II clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. The firm is engaged in developing a cell-based therapy candidate, ThermoStem Program, which targets obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). The company has also licensed an investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. The company also operates a commercial biocosmeceutical platform.
Read More

BioRestorative Therapies Inc (BRTX) Chart

Key Statistics of BioRestorative Therapies Inc (BRTX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.38$0.40

Today's Open

$0.38

Volume

300.76K

P/E Ratio (TTM)

-

52 Week Range

$0.16$1.89

Market Cap

4.92M

Avg. Volume

29.65M

Dividend Yield

-

Financial Metrics & Statements of BioRestorative Therapies Inc (BRTX)

FAQ's for BioRestorative Therapies Inc (BRTX)

  • According to Musaffa’s Shariah screening methodology, BioRestorative Therapies Inc (BRTX) is currently classified as NOT HALAL as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BioRestorative Therapies Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in BioRestorative Therapies Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of BioRestorative Therapies Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of BioRestorative Therapies Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of BioRestorative Therapies Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.